EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Noninvasive Follicular Thyroid Neoplasia With Papillary‐Like Nuclear Characteristics (NIFTP): Clinico‐Pathological Analysis in a Chilean Centre

Iván Muñoz, Marlín Solórzano, Ignacio Fuentes, José Miguel González, Joel Falcón Acevedo, Catalina Ruiz Rademacher, Joaquín Viñambres Giavio, Rodolfo Cabello Torres, Pablo Montero Miranda, Hernán González Díaz, Antonieta Solar, Francisco Cruz Olivos und 3 weitere

Clinical Endocrinology · 2025

DOI: 10.1111/cen.70026 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Endocrinology, 2025. Verfasst von Iván Muñoz und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Adenocarcinoma, Follicular. Die Arbeit nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Noninvasive follicular thyroid neoplasia with papillary‐like nuclear characteristics (NIFTP) is characterised by an indolent behaviour and was defined in 2016 to avoid overtreatment in differentiated thyroid cancer (DTC).

Objectives

To report the clinicopathological characteristics and outcomes of patients with NIFTP treated at a Chilean centre between 2016 and 2023.

Design

Observational retrospective study.

Methods

Of 1103 patients with thyroid neoplasia treated with surgery, 104 (9.42%) had NIFTP. Clinicopathological variables were recorded, including ultrasound characteristics, fine‐needle aspiration biopsy (FNAB) results, genetic testing when available, type of surgery, tumour size, and follow‐up data.

Results

Of 104 patients, 85 (81.7%) were female, age of 44 ± 14.2 years and a median tumour size of 1.7 cm (range 0.1–7.1). Eighty‐six (82.7%) had available preoperative staging ultrasound: 1 (1.2%), 39 (45.3%), 38 (44.2%), and 8 (9.3%) were ACR‐TIRADS 2, 3, 4, and 5, respectively. Sixteen (15%) NIFTP were incidental, which were smaller than non‐incidental NIFTP (median 0.4 cm (0.1–2.2) vs. 1.9 cm (0.6–7.1), p < 0.001). Of the 86 FNAB results available, 2 (2.3%), 10 (11.6%), 20 (23.3%), 24 (27.9%), and 30 (34.9%) were Bethesda I, II, III, IV, and V, respectively. Forty‐three patients (41.3%) were treated with lobectomy, 58 (55.8%) with total thyroidectomy (TT), and only 3 (2.9%) with TT and lymph node dissection. In Bethesda II patients, surgery was indicated in cases of nodule growth, showing a larger tumour size than other Bethesda categories (3.0 ± 1.4 vs. 1.8 ± 1.02 cm, p = 0.015). ThyroidPrint® was performed in 12 patients with Bethesda III or IV, resulting suspicious in 11 (92%): of these, 8 (67%) underwent lobectomy. There were no significant differences between lobectomy and TT regarding sex, ACR‐TIRADS, tumour size, or ThyroidPrint® results. Twelve (11.5%) were multifocal and 5 (4.8%) bilateral. Fifty‐two patients (54%) were followed for ≥ 1 year using follow‐up criteria and response to treatment for low‐risk DTC recurrence. Thirty‐four (65%) had excellent response, 15 (28.8%) indeterminate (13 (25%) by biochemical criteria and 2 (3.8%) by ultrasound), 3 (5.7%) incomplete biochemical (2 (3.8%) due to elevated Tg and 1 (1.9%) due to elevated anti‐Tg antibodies), and none with incomplete structural response. There were no differences between lobectomy and TT ± lymph node dissection regarding the type of response. At the end of the follow‐up, there were no deaths, and no new interventions were required due to recurrence.

Conclusions

In this series, NIFTP showed indolent behaviour and excellent prognosis. Ultrasonographically, 90% presented as ACR‐TIRADS 3 or 4, with less than 10% as ACR‐TIRADS 5. Regarding FNAB, nearly half were indeterminate, one‐third were Bethesda V, and none Bethesda VI. No significant differences in clinical outcomes were found between lobectomy and TT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsAdenocarcinoma, FollicularHumansFemaleMaleAdultMiddle AgedRetrospective StudiesChileBiopsy, Fine-NeedleThyroidectomyAgedUltrasonographyYoung Adult

Stichwörter der Autor:innen

biopsy, fine‐needlequality of lifethyroid neoplasmsthyroid nodulethyroidectomy, trends

Autor:innen und Institutionen

  • Department of Endocrinology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • CETREN: Centro de estudios traslacionales de Endocrinología UC, Santiago, Chile.
  • Department of Surgical Oncology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Department of Pathology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
  • Department of Radiology, Nuclear Medicine, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.

ORCID-Profile: Lorena Mosso Gómez, José Miguel Domínguez

Zitieren

APA

Muñoz, I., Solórzano, M., Fuentes, I., González, J. M., Acevedo, J. F., Rademacher, C. R., Giavio, J. V., Torres, R. C., Miranda, P. M., Díaz, H. G., Solar, A., Olivos, F. C., Gómez, L. M., Franco, N. L., & Domínguez, J. M. (2025). Noninvasive Follicular Thyroid Neoplasia With Papillary‐Like Nuclear Characteristics (NIFTP): Clinico‐Pathological Analysis in a Chilean Centre. Clinical Endocrinology. https://doi.org/10.1111/cen.70026

Vancouver

Muñoz I, Solórzano M, Fuentes I, González JM, Acevedo JF, Rademacher CR, et al. Noninvasive Follicular Thyroid Neoplasia With Papillary‐Like Nuclear Characteristics (NIFTP): Clinico‐Pathological Analysis in a Chilean Centre. Clinical Endocrinology. 2025. doi:10.1111/cen.70026

BibTeX
@article{Muoz2025,
  author = {Muñoz, Iván and Solórzano, Marlín and Fuentes, Ignacio and González, José Miguel and Acevedo, Joel Falcón and Rademacher, Catalina Ruiz and Giavio, Joaquín Viñambres and Torres, Rodolfo Cabello and Miranda, Pablo Montero and Díaz, Hernán González and Solar, Antonieta and Olivos, Francisco Cruz and Gómez, Lorena Mosso and Franco, Nicole Lustig and Domínguez, José Miguel},
  title = {Noninvasive Follicular Thyroid Neoplasia With Papillary‐Like Nuclear Characteristics (NIFTP): Clinico‐Pathological Analysis in a Chilean Centre},
  journal = {Clinical Endocrinology},
  year = {2025},
  doi = {10.1111/cen.70026}
}
Kostenlos starten →